| Application no. and date | 19167626.1 (espacenet) (Federated) (European Patent Register), 20150619 | | Patent/reg. no. and date | DK/EP 3564244, 20230913 | | Publication date | 20191106 | | Priority no. and date | US 201462015238 P, 20140620, US 201462017183 P, 20140625 | | EP pub. no. and date |
EP 3564244 20191106 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | | | Inventor | ZIA, Vahid, c/o Gilead Sciences Inc.
333 Lakeside Drive
Foster City, CA 94404, US,
CARRA, Ernest A., c/o Gilead Sciences Inc.
333 Lakeside Drive
Foster City, CA 94404, US,
CHEN, Irene, c/o Gilead Sciences Inc.
333 LakesideDrive
Foster City, CA 94404, US,
KEATON, Katie Ann, c/o Gilead Sciences Inc.
333 Lakeside Drive
Foster City, CA 94404, US | | Representative | | | Opponent | | | IPC Class | A61K 31/537 (2006.01) , A61P 31/18 (2006.01) , C07D 498/14 (2006.01) | | Title | CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
